Chronic and noncommunicable diseases
FHI 360 synthesizes experience into an applied response to the U.S. and global health issue of chronic and noncommunicable diseases, such as cardiovascular disease, diabetes and obesity.
Clinical trials design and implementation
FHI 360 conducts and supports clinical research in resource-limited settings around the world. We bring technical, regulatory and cultural expertise to regions where the need and opportunity for clinical research are greatest. We work with governments, ministries of health and local partners to build capacity, strengthen research services, test products and improve lives.
- Contraception and family planning
Contraceptive Technology Innovation
FHI 360 spearheads research to expand the contraceptive method mix by identifying new technologies and refining existing ones to give women a broad selection of options to meet their changing needs throughout their reproductive lives.
- Emerging pandemic threats
FHI 360 conducts epidemiologic studies using a variety of research designs, such as cohort, case-control, case-cohort and partially randomized patient-preference designs.
Ethical and responsible conduct of research
The science of improving lives is built on the ethical and responsible conduct of research. FHI 360 develops award-winning ethics training curricula and tools to support community engagement in health research and conducts its own research to improve informed consent and other ethical requirements.
FHI 360 offers health economics research, health services research and social and behavioral sciences research.
FHI 360 is a leader in developing and implementing some of the most critical tools informing the worldwide response to the HIV/AIDS epidemic. These essential tools include behavioral surveillance surveys (BSS) and biological and behavioral surveillance surveys (BBSS).
Health systems strengthening
FHI 360 programs improve health system performance and ensure delivery of high-quality services in resource-limited settings.
HIV and AIDS
FHI 360’s comprehensive approach to fighting HIV and AIDS is driven by innovative research, aggregated evidence and a long track record of engaging directly with communities around the world most impacted by the epidemic.
FHI 360 addresses the gaps between knowledge development and widespread uptake of evidence-based innovations to improve health and save lives.
Infectious and tropical diseases
FHI 360’s work in infectious and tropical disease supports rapid identification and treatment, best methods in prevention, and improved understanding of the sociocultural and environmental conditions that allow diseases to flourish.
Clinical laboratory quality assurance
FHI 360 helps to improve and assure the quality of clinical laboratories in underresourced countries to produce reliable and timely test results.
- Market development and product introduction
Maternal, newborn and child health
Mothers, infants and children are dying unnecessarily every day in countries around the world. From decades of research and program implementation, we know where these deaths occur, how they occur, and, most importantly, what can be done to reduce them.
- One Health
Product quality and compliance
Product quality and compliance at FHI 360 is dedicated to ensuring that global health commodities comply with international standards for quality, safety and efficacy and perform per manufacturer claims.
Biostatistics and data sciences
At FHI 360, we work to ensure research data excellence so that our studies produce meaningful and useful results. We also offer comprehensive quantitative sciences, biostatistics and data management services to our clients.
Sexual and reproductive health
FHI 360 research and programs enable women, men and youth to make informed decisions about their reproductive and sexual health. For more than 40 years, FHI 360 has played a pioneering role in helping inform family planning policies and increase the availability of high-quality contraceptive methods, counseling and services around the world.
FHI 360 is committed to moving evidence into practice to improve the health and development of the people and communities we serve.
Social and behavior change
FHI 360 uses a socio-ecological lens to view the complex interplay between individual, interpersonal, community and societal factors that affect behaviors. We select interactive, participatory strategies to ensure a holistic view of people’s desires and needs and the barriers and facilitators to change.
Technical quality and technical assistance
FHI 360’s global team of experts works to improve the quality of health programs. We have substantial technical expertise in health, population, nutrition, strategic information, and monitoring and evaluation.
- Type 2 Diabetes Prevention and Management
Water, sanitation and hygiene
Good health cannot be achieved in unhealthy environments. Access to safe water, adequate sanitation and proper hygiene (WASH) reduces illness and death. FHI 360’s WASH experts help create clean environments and promote behaviors supportive of healthy households and communities.
- CDC's Enhancing Global Health Security (EGHS)
- Infectious Disease Detection and Surveillance (IDDS)*
- USAID Tuberculosis Private Sector (USAID TBPS)
- Tunisian Health Center for University Research Excellence & Sustainability (CURES)
- Global Health Supply Chain-Quality Assurance Program (GHSC-QA)
- Act to End Neglected Tropical Diseases (NTDs) | West (Act | West)
- USAID End TB Tajikistan Activity
- HIV Free - Cameroon
- Capacity Development and Support Program (CDS)
- Meeting Targets and Maintaining Epidemic Control (EpiC)
Director of Global Health and Population (GHP)
Regional Director, East and Southern Africa Regional Office
Director, Global Health Programs
Director, Reproductive, Maternal, Newborn, and Child Health
Scientist, Global Health, Population and Nutrition
Director, U.S. Programs
Technical Director - COVID Response
Director, Infectious Diseases
Senior Science Advisor
Stories & Highlights
- Ukraine: 42 civilians killed every day in two years of war
- FHI 360 conducting trial for Casea S, a biodegradable contraceptive implant
- How the right messaging can improve PrEP equity in the U.S.
- Navigating the path to neglected tropical disease elimination following a historic funding pledge
- Why are cases of HIV infections on the rise among girls?
- Finding a job when unemployment is over 30%
- A Ugandan mother's fight against malnutrition
- Opinion: 3 steps to bolster locally led HIV response
- The power of peers: Reaching key populations in Mozambique
- Male engagement groups help create a new cycle of positive domestic practices